Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study
ConclusionsOur results support the importance of assessing the potential development of NAFLD in schizophrenia spectrum patients receiving antipsychotic medication.
Source: Psychopharmacology - Category: Psychiatry Source Type: research
More News: Abilify | Alcoholism | Cardiology | Cardiovascular | Fatty Liver Disease (FLD) | Geodon | Heart | Hypertension | Liver | Liver Disease | Men | Non-alcoholic Fatty Liver Diseases (NAFLD) | Psychiatry | Risperdal Consta | Schizophrenia | Seroquel | Study | Urology & Nephrology | Ziprasidone